We are living in an era in which the world has become a “global village,” with “shrinking”
national borders and liberalization of trade between countries. The populace of discrete
countries can no longer consider themselves remote from the risk of incursion of a
wide variety of infectious diseases of public health and veterinary significance.1,
2 It is widely acknowledged that increasing globalization, whether with respect to
movement of people or trade in animals or animal products, provides greater opportunities
for the rapid and widespread dissemination of a variety of diseases from country to
country and within countries, a situation that is historically unprecedented. The
ever-increasing volume of international movement has given rise to a major paradigm
shift in the geographic distribution of many diseases. Fewer and fewer diseases can
now be regarded as “geographically restricted” or “compartmentalized” to certain areas
of the world.
The list of human and animal pathogens that have been accidentally introduced or reintroduced
into regions or countries where they were never previously known to occur or from
which they were eradicated in the past is expanding.
3
Examples of the more important human diseases and disease agents spread through international
travel include tuberculosis, severe acute respiratory syndrome (SARS virus), influenza,
malaria, cholera, Lassa fever, and Ebola virus. The roster of animal diseases with
convincing evidence of spread through international movement or trade in animal products
is also extensive and includes foot-and-mouth disease, hog cholera, exotic Newcastle
disease, equine influenza, glanders, canine parvovirus, West Nile virus (WNV), and
more recently, highly pathogenic avian influenza (H5N1 virus). Some animal disease
pathogens (e.g., WNV, Venezuelan equine encephalomyelitis [VEE] virus, and Burkholderia
mallei) are important zoonoses and can give rise to significant morbidity and mortality
in humans, as well as in various animal species.
Many transboundary animal disease incursions are relatively transient in duration;
the diseases are effectively controlled and eradicated within a limited time after
their introduction. However, this is not always the case. Some disease pathogens are
highly adaptable and very successful in establishing themselves in a new geographic
environment. This is well illustrated by the behavior of WNV over the past 10 to 15
years both in Europe and in the Western Hemisphere. The virus has been confirmed in
an increasing number of European countries, including but not necessarily limited
to Hungary, Greece, Italy, Spain, and Portugal; in some of these countries there is
evidence of overwintering of the virus. An analogous situation exists in various countries
in the Western Hemisphere in which WNV has adapted itself remarkably well and become
endemic since its first known introduction into North America (United States) in 1999
and now has resurged again in 2012 in humans in the United States.
4
It took only 5 years for WNV to become established in 48 of the 50 states in the United
States.
Growth of Horse Industries Worldwide
The horse is unique not only because of the longevity of the species and significant
financial value of individual animals, but also, more importantly, because of the
frequency with which horses are shipped between countries and between continents for
various commercial purposes. Frequently taken for granted, the advent of commercial
jet aircraft transportation has been the single most important factor in facilitating
the unparalleled growth in international trade in equids, semen, and embryos that
has taken place over the past 50 years or so.
5
Air travel has revolutionized the speed and ease with which horses can be shipped
between or within countries and has largely replaced other means of transporting horses
over considerable distances by land or by sea. In today's world, the horse can truly
be considered no less an “international jetsetter” than its human counterpart.
Changing trends in the equine industry worldwide have contributed significantly to
the evolving nature of the international trade in equids, semen, and embryos. In the
process, however, such changes have inevitably increased the risk of spread of various
equine diseases. Before elaborating on specific factors involved in the international
dissemination of equine diseases in detail, it is important to appreciate the transformation
that the equine industry in many countries has undergone over the past 50 to 60 years.
Since the 1960s, there has been an unprecedented upsurge in the growth of the horse
industry in many countries, both for commercial and recreational purposes. Consideration
of the increased prominence of the equine industry worldwide must acknowledge the
resurgence of interest in the horse through leisure activities. The 2005 Economic
Impact Study carried out in the United States identified recreation as the single
largest equine-related activity, involving 3.9 million horses of an estimated national
equid population of 9.2 million animals.
6
The most significant factor in this development was the favorable economic climate
enjoyed by these countries over this period. National economics flourished from changes
in the global market structure under various multinational trade agreements.
7
Among the industries to benefit has been the equine industry, with a resultant increase
in the volume of international trade in equids and semen. The trend toward globalization
of the equine industry received further impetus after establishment of the World Trade
Organization (WTO) in January 1995.
8
The primary goal of the WTO is to promote freer economic exchange between member countries
through reduction or elimination of protectionist barriers to trade.
9
Regrettably, continued growth in the horse industry worldwide has slowed in the last
several years as a consequence of the recession that has significantly impacted the
national economies of many countries. Notwithstanding the current economic downturn,
emergent equine industries are being developed in the Republic of Korea and the People's
Republic of China.
Basis for International Movements and Trade in Equine Germplasm
An appreciation of the nature of international movement of equids is fundamental to
understanding how trade in horses, semen, and embryos can contribute to the spread
of equine diseases.
5
Horses are shipped internationally for various reasons. Some are intended for permanent
entry and others for temporary entry into the importing country. Most frequently,
horse travel between countries is for the purpose of competing in a particular performance
event. Among the more prominent and better known performance activities are racing,
show jumping, dressage, eventing, driving, polo vaulting, reining, and endurance riding.
Shipment of stallions and mares for breeding purposes is another important facet of
the international movement of equids. This is especially significant in the case of
the Thoroughbred industry worldwide, which does not allow the use of artificial insemination
(AI) or embryo transfer in the breed. Over the years, significant growth has occurred
in the practice of “shuttling” stallions, Thoroughbreds and Standardbreds between
countries in the Northern and Southern Hemispheres.
10
Horses are also shipped internationally to be sold at a commercial sale or in the
case of a change in ownership.
A final category of horse movement that applies primarily to countries other than
the United States is the shipment of horses for processing, primarily for human consumption.
Several hundred thousand horses are shipped annually from Eastern Europe, Northern
Africa, and certain countries in South America to various countries in Western Europe,
including but not exclusive of Italy, Germany, France, and Belgium, for this purpose.
3
As with live animal movements, the international trade in equine semen and embryos
has expanded significantly in recent years.
5
This is largely the result of the acceptance of AI in all the major horse breeds except
Thoroughbreds.
11
Economic Impact
A major factor contributing to the importance of international trade in equids, semen,
and embryos has been the increased socioeconomic significance of the equine industry
in a growing number of countries worldwide. The horse has joined the list of animal
and plant commodities that are traded globally.
3
To date, relatively few countries have attempted to assess the impact of their respective
industries on their national economies. Limited studies have been done in the United
Kingdom, Ireland, and Mexico, all of which underscore the important cultural and economic
value of the horse in these countries.
12
Australia and the United States have carried out comprehensive studies of their respective
equine industries.6, 13, 14, 15 The American Horse Council Foundation commissioned
an economic impact study of the horse industry in the United States in the mid-1990s
6
and again 10 years later.
14
Comparison of the findings of the two studies revealed that the U.S. equid population
had increased considerably over the intervening period, from an estimated 6.9 million
in the mid-1990s to 9.2 million in 2005. Both impact studies dramatically demonstrated
the major contribution of the horse industry to the national economy. In the 2005
study, the combined contributions of the direct, indirect, and induced effects of
the industry (in terms of Gross Domestic Product) were assessed at more than $102
billion.
6
The industry provides considerable employment, estimated at 1.4 million full-time
equivalent jobs annually. Until the widespread financial recession in the last few
years, revenue from the sale of equids had risen steadily, grossing in excess of $2
billion at its peak.
Changing Trends
Not surprisingly, changing trends in the horse industry over the past 40 to 50 years,
most of them commercially driven, have been a major influence on the evolving nature
of international trade in equids, semen, and embryos.
7
As already mentioned, horses are most frequently transported between countries to
compete in various performance events, racing, show jumping, and other types of equestrian
sports. The number of highly prestigious and lucrative equine competitive events has
proliferated around the world in the past 15 to 20 years.
3
This is well illustrated by the increase in number of major equestrian events held
under the aegis of the International Equestrian Federation (FEI); these events have
nearly doubled over the past 8 years alone. Attracted by the considerable prize monies
involved, owners are shipping their horses many thousands of miles, sometimes from
the Northern to the Southern Hemisphere, or vice versa, to compete in international
equestrian or racing events. Transporting horses over significant distances for competition
purposes has inherent risks (e.g., traumatic injuries, shipping fever). Nonetheless,
the number of prestigious international events will likely continue to increase, with
escalation in the volume of movement of horses, despite the inherent health risks
involved.
Another important economic trend that has grown in volume, especially over the past
20 years, is the practice of dual-hemisphere breeding of stallions, in which a stallion
fulfills a breeding season in both hemispheres in the same calendar year.
10
This is more popular and economically more advantageous, for both stallion and mare
owner alike, than transporting mares between hemispheres for breeding purposes (e.g.,
shipping a mare from the Southern to the Northern Hemisphere to be bred in Southern
Hemisphere time). The vast majority of “shuttle stallions” are shipped from the Northern
to the Southern Hemisphere. While many of them are Thoroughbreds, Standardbred stallions
are also shuttled. They originate principally in Ireland, the United Kingdom, France,
the United States, Canada, and Japan and travel primarily to Australia and to a lesser
extent, New Zealand, Argentina, Chile, Brazil, Columbia, Peru, Venezuela, and South
Africa.
As noted, acceptance of AI by an increasing number of breed registries has been another
major development in the horse industry in recent years.
11
Technical advances in preserving the fertilizing capability of equine sperm and the
viability of equine embryos have provided the basis for the expanding trade in fresh-cooled
and especially frozen semen being shipped internationally. There is greater demand
among breeders for access to particular preeminent bloodlines among those breeds in
which AI is permitted.
In summary, continued proliferation in the number of prestigious equestrian and racing
events, dual-hemisphere breeding of stallions, and the legalized use of AI in all
the major horse breeds, except the Thoroughbred, are the principal, economically driven
trends in the equine industry, and these trends are responsible for the sustained
growth in international trade in equids, semen, and embryos worldwide.
Factors Influencing Global Distribution of Equine Diseases
A diversity of related and unrelated factors have been identified with the potential
to influence the global distribution of equine infectious diseases.3, 5, 10 These
include the international trade in equids, semen, and embryos; multinational trade
agreements; emergent diseases; variants of established equine pathogens; climatic
disturbances; availability of new vectors; migration of amplifying/reservoir hosts
or vectors of specific pathogens; disease spread from feral equids; reliability of
preexport laboratory testing; and acts of agroterrorism.
International Trade in Equids, Semen, and Embryos
Movement of equids and trade in semen represent the most important factors responsible
for the spread of equine diseases.3, 16, 17, 18, 19 With the progressive growth in
international trade in equids, semen, and embryos, the risk of dissemination of a
variety of equine diseases, both within and between countries, has increased commensurately.
This has been amply borne out by the significant number of times that specific diseases
have been introduced or reintroduced into countries or geographic regions of the world
through the importation of equids or semen. Most vulnerable to the risk of disease
incursions are countries with a significant import trade in equids, semen, and embryos
such as the United States.
The risk of incursion of transboundary equine diseases can be influenced in part by
whether the equids being imported are approved for temporary or permanent entry into
a country.
3
An exception would be those diseases transmitted primarily by the respiratory route,
such as equine influenza, equine herpesvirus-1 (EHV-1) and -4 (EHV-4)–related diseases,
strangles, and glanders. Spread of respiratory infections can occur irrespective of
whether importation is temporary or permanent. On the other hand, in the case of equine
diseases characterized by the carrier state, the risk of transfer of these diseases
is much greater in horses taking up permanent residence in a country. This applies
to vector-borne diseases, such as equine infectious anemia (EIA) and equine piroplasmosis
(EP), as well as infections transmitted by the venereal route such as contagious equine
metritis (CEM), equine viral arteritis (EVA), and dourine (Trypanosoma equiperdum).
Clearly, the mode(s) of transmission of individual equine diseases has an important
influence on how successfully they can be transmitted to and spread within a naïve
or unprotected equine population in an importing country. Any shipment of equids may
include one or more animals incubating or subclinically infected with a particular
agent or that are asymptomatic carriers of a specific pathogen. Examples include equine
herpesviruses (EHV-1, EHV-3, and EHV-4), equine arteritis virus, EIA virus, Streptococcus
equi subsp. equi, Taylorella equigenitalis, Burkholderia mallei, Salmonella spp.,
T. equiperdum, Theileria equi, and Babesia caballi.
3, 7
Respiratory transmission by an acutely infected equid is widely considered one of
the most efficient means of disease transfer. Respiratory-borne diseases, such as
equine influenza virus (EIV), equine rhinopneumonitis caused by EHV-1 or EHV-4, and
strangles, have been spread repeatedly between countries through international movement
of horses (Table 63-1
). Venereal transmission is also of major significance with respect to imported breeding
animals, both stallions and mares, which may be carriers of specific pathogens (e.g.,
EAV, EHV-3, T. equigenitalis, T. equiperdum, and certain serotypes of Klebsiella pneumoniae
and Pseudomonas aeruginosa).
Table 63-1
Epidemics of Equine Influenza Resulting from International Movement of Equids, 1963-2012
Virus Strain
Importing Country
Year
Source
Equine-2 influenza A virus
United States
1963
South America
Equine-2 influenza A virus
Western Europe
1965
North America
Equine-1 influenza A virus
England, Ireland
1977
Continental Europe
Equine-1 influenza A virus
Singapore, Malaysia
1977
Europe
Equine-2 influenza A virus
England, Ireland
1979
Continental Europe
Equine-2 influenza A virus
South Africa
1986
United States
Equine-2 influenza A virus
India
1987
France
Equine-2 influenza A virus
Jamaica
1989
United States
Equine-2 influenza A virus
Hong Kong
1992
England and Ireland
Equine-2 influenza A virus
United Arab Emirates (Dubai)
1995/96
United States
Equine-2 influenza A virus
Puerto Rico
1997
United States
Equine-2 influenza A virus
Philippines
1997
United States
Equine-2 influenza A virus
South Africa
2003
United States
Equine-2 influenza A virus
Japan
2007
United States/Europe
Equine-2 influenza A virus
Australia
2007
Japan
Modified from Timoney PJ: Equids and equine semen: international trade vs. disease
control. In Proceedings of Eighth International Conference on Equine Infectious Diseases,
Newmarket, England, 1999, R&W Publications.
A further category of carriers are equids persistently infected with disease agents
such as EIA virus, T. equi, and B. caballi, which are primarily vector-borne infections
but can also be transmitted iatrogenically. Besides the potential for many equine
diseases to be introduced and effectively spread by respiratory, venereal, or vector-borne
routes, agents can be transferred between countries by other means, which, although
less frequently encountered, should not be overlooked. A limited number of pathogens
(e.g., EHV-1 and EHV-4, T. equigenitalis) can be introduced into a country through
the importation of a pregnant mare that is harboring these organisms in utero. In
such cases, the potential for spread of these pathogens is at the time of foaling.
3
A final means of introduction of a disease agent is through importation of an equid
infested with the intermediate state of a parasite such as the larvae of the botfly,
Cochliomyia hominivorax, the cause of screwworm myiasis.
3
In sporadic but repeated cases, horses imported into the United States from certain
South American countries (e.g., Argentina, Venezuela) have been found infested with
these larvae on postentry inspection.
Even though most of the international spread of equine diseases results from the movement
of equids, usually horses, trade in semen is also of proven importance in the global
dissemination of certain equine pathogens, including EAV, T. equigenitalis, K. pneumoniae,
and P. aeruginosa.
3, 16, 17 Imported virus-infective semen, primarily from Warmblood stallions in Europe,
was responsible for extensive and economically significant outbreaks of EVA in the
United States and in Argentina in 2010, in some cases associated with abortion and
the death of young foals.16, 18
Over the past 40 years, numerous outbreaks or epidemics of particular equine diseases
have resulted from the importation of an infected animal(s) or infective semen
3
(Table 63-2
). African horse sickness (AHS) and VEE are the two most dreaded equine diseases,
and both have been responsible for devastating epidemics. The most recent epidemics
of AHS outside the endemic areas in sub-Saharan Africa occurred during 1987-1991 in
Spain, Portugal, and Morocco, causing significant economic losses and having a major
impact on international trade in equids from affected countries.
19
The source of the original outbreak in Spain in 1987 was traced to the importation
of 10 zebras from Namibia, which transited through Portugal en route to a safari park
near Madrid.
Table 63-2
Disease Outbreaks and Epidemics Related to International Movement of Equids and Semen,
1959-2012
Disease
Importing Country
Year
Source
African horse sickness
Middle East, Southwest Asia, India
1959
Extension from epidemic in Africa
Spain, Cyprus
1987
Imported zebra from Namibia
Morocco, Portugal
1989
Extension from epidemic in Spain
Contagious equine metritis
England, Ireland
1977
Imported carrier animal
Australia
1977
Imported carrier stallions from Europe
Brazil
1977
Imported carrier animal from Europe
United States
1978
Imported carrier animal from Europe
Japan
1980
Imported carrier animal from Europe
England
1996
Imported carrier stallion from Europe
United States
2000
Imported carrier stallion from Denmark
South Africa
2011
Imported carrier stallion from Europe
Equine herpesvirus myeloencephalopathy
United States
2006
Imported horses from Germany
Equine infectious anemia
England
1974
Imported carrier mare from Italy
Ireland
2006
Imported plasma from Italy
Equine viral arteritis
United States
1986/87
Imported carrier stallion or semen from Europe
England
1993
Imported carrier stallion from Europe
South Africa
1994-1998
Imported semen from Europe
United States
1996-2005
Imported carrier stallions or semen from Europe
Argentina
2010
Imported semen from the Netherlands
Glanders
United Arab Emirates (Dubai)
2004
Middle East
Germany
2006
Imported horse from Brazil
Kuwait
2009/10
Imported horses from Syria
Bahrain
2010
Imported horses from Syria and Kuwait
Lebanon
2011
Imported horses from Syria
Piroplasmosis
United States
1959
Imported Cuban horses with Babesia caballi
United States
2009/2010
Imported horses from Mexico
Venezuelan equine encephalomyelitis
United States
1971
Extension from epidemic in South America, Central America, and Mexico
Modified from Timoney PJ: Equids and equine semen: international trade vs. disease
control. In Proceedings of Eighth International Conference on Equine Infectious Diseases,
Newmarket, England, 1999, R&W Publications.
Equine influenza has frequently been spread through international movement and has
occasionally been responsible for widespread epidemics of disease in immunologically
naïve or inadequately protected horses. Such occurrences have had a major economic
impact on the racing industries in affected countries. The first recorded introduction
of EIV into the racing population in Hong Kong in 1986 resulted in the cancellation
of seven race meetings and financial losses totaling almost $1 billion.
20
Similarly, the disease had a major impact on the racing industry in South Africa after
it was first introduced in 1992
21
and reintroduced in 2003.
22
The latter epidemic affected an estimated 3700 horses in training (40% of the country's
racehorse population) at Cape Town, Johannesburg, and Port Elizabeth and approximately
3000 other equids. Loss in revenue to the equine industry from this epidemic was estimated
at more than 60 million rand. The most recent major epidemic of EIV occurred in Australia
in 2007.
23
This was traced to the importation of a number of subclinically infected shuttle stallions
from Japan. Breaches in biosecurity at a postentry quarantine station led to escape
of the virus and very extensive spread of the disease among the horse populations
in southern Queensland and New South Wales. Estimated economic impact of this epidemic
exceeded 1 billion dollars.
The widespread occurrence of CEM in Kentucky in 1978 exemplifies the major economic
impact that introduction of a transboundary equine disease can have on a previously
unexposed naïve breeding population.
3
The disease was traced to the importation of two carrier stallions from Europe in
the fall of 1977 and resulted in major disruption to the 1978 breeding season and
an estimated financial loss to the state's Thoroughbred breeding industry of at least
$4 million. More recently, there was a second major CEM event in the United States
that was first discovered in late 2008.
24
The source of T. equigenitalis was believed to have been a carrier stallion imported
from Denmark in 2000. Approximately 1100 stallions and mares were exposed during the
occurrence, with the cost to the industry and the government of several million dollars.
Experience over the years has repeatedly reaffirmed the ease with which various equine
diseases have been disseminated globally through the international trade in equids
and semen.
5
Such incursions have had major financial repercussions for the horse industry in affected
countries. Aside from significant disruption to racing or other equine performance
events and perhaps to a country's breeding industry, occurrences of transboundary
diseases can have a long-term effect on international trade. This can best be illustrated
by the restrictions on importation of equids that many countries impose on any country
or region thereof affected with AHS. In addition to equine health and economic consequences,
the introduction of certain transboundary equine diseases (e.g., VEE, glanders) can
have a major impact on public health.
Multinational Trade Agreements
In an era of increasing globalization, facilitation of trade between countries through
the reduction or elimination of restrictive trade practices has been the goal of various
bilateral and multinational trade agreements. The European Union Free Trade Area,
the North American Free Trade Agreement (NAFTA), and the World Trade Organization
(WTO) are among the major world trading groups, markets, and agreements.
3
Formation of the WTO at the Uruguay Round of Multilateral Trade Negotiations in 1994
marked a significant change in how its member countries could regulate for the control
of infectious diseases of plants and animals under the organization's Sanitary and
Phytosanitary Agreement.
8
The key provisions of that agreement are aimed at facilitating international trade
in animals, including animal germplasm, by reducing preimport and postimport health
requirements among participating countries.
7
It could be rightly argued that easing trade restrictions and related testing requirements
enhances the risk of introducing transboundary diseases while limiting a country's
ability to protect its equine industry from the incursion of various equine pathogens.
Currently, there is no compelling justification for reducing existing preentry and
postentry health requirements for equids imported into the United States on the pretext
of furthering international trade. To do so would undoubtedly heighten the risk of
introducing a range of equine diseases, some transboundary and others presently endemic
in the United States equid population. An example in point is the number of stallions
and mares imported from Europe over the past 15 years that turned out to be carriers
of CEM on postentry quarantine and testing. All had been tested in their respective
countries of origin and were certified negative for the carrier state prior to export.
The potential economic consequences for the domestic horse industry from any such
incursions could far outweigh the financial benefits to be gained from facilitating
international trade.
Emergent Diseases
Over the past 40 to 50 years, several previously unrecognized diseases have been described
that can affect horses and other members of the family Equidae.
2, 5, 7 The list of “new” or emergent equine pathogens continues to grow, as it does
for humans and other animal species. It currently includes several bacterial diseases,
such as CEM, Potomac horse fever, equine granulocytic ehrlichiosis, equine proliferative
enteropathy, and nocardioform placentitis and abortion, and a number of viral diseases,
including equine encephalosis, Getah virus infection, Hendra virus infection, Nipah
virus infection, and Salem virus infection. The geographic distribution of most of
these diseases has remained essentially the same as when they were originally identified.
A notable exception is CEM, which has been spread to various countries worldwide through
the international movement of carrier stallions and mares.
3
Additional equine diseases will undoubtedly be discovered. Containing these diseases
and preventing their dissemination globally will require the cooperation and combined
efforts of horse industries and animal health officials in the country or countries
in which they are initially recognized.
New Variants of Established Pathogens
Natural mutation of certain equine pathogens has given rise to variants and strains
of enhanced virulence for the horse, as illustrated by several examples in the past
20 years. In 1989 a novel strain of EIV (H3N8), the Jilin'89 strain of equine-2 influenza
A virus, emerged in China.
25
Thought to be of avian origin, this particular virus strain was responsible for tens
of thousands of cases and numerous deaths in the indigenous equid population. If it
had spread outside China, this strain of H3N8 could have had devastating consequences
for other unprotected equine populations.
Significant outbreaks of equine encephalomyelitis in southwestern Mexico in 1993 and
again in 1996 provided the first confirmed evidence of the emergence of a strain of
VEE virus subtype IE with the capability to cause illness and associated mortality
not only in humans but also in equids.
26
Before these outbreaks, the endemic IE virus subtype was not considered to have the
potential to cause widespread disease in equids. Clearly, similar variants of this
subtype of VEE virus may reemerge in the future and spread to other geographic areas,
which could include Central America and the United States.
The most recently recognized example of emergence of a variant of an established equine
pathogen is the identification of strains of EHV-1 with enhanced neuropathogenicity
for the horse. These neuropathogenic strains of the virus appear to have evolved as
a result of a single-point mutation in the viral DNA polymerase gene.
27
Such strains have been shown to cause higher clinical attack rates and greater case-fatality
rates than virus strains lacking this mutation. Available evidence from outbreaks
of equine herpesvirus myeloencephalopathy in the United Kingdom, France, and the United
States indicates that the frequency of this disease is increasing in these countries.
Because of the high percentage of horses that can become latent carriers of this infection,
these neuropathogenic strains of EHV-1 will inevitably become more widely disseminated
through the international movement of equids and there is evidence to indicate this
is already occurring.
Climate Disturbance Effects
There is mounting evidence that climate-related phenomena, such as El Niño-southern
oscillation and global warming, can have an influence on the occurrence and distribution
of certain diseases, especially vector-borne diseases such as AHS, equine encephalosis,
and the equine viral encephalomyelitides.28, 29 The increased temperatures and altered
rainfall directly linked to such phenomena are likely to affect the range and biologic
behavior of arthropod vectors and intermediate, amplifying/reservoir hosts, as well
as the viability and maturation rates of infective agents in those vectors.
30
African horse sickness, equine encephalosis, and vesicular stomatitis are diseases
affecting the horse that can be spread through windborne carriage of infected insect
vectors such as Culicoides spp. Study of the climatic patterns for the western region
of South Africa, where most epidemics of AHS have occurred, has shown that all but
1 of the 14 epidemics of the disease recorded since 1803 have been in El Niño years.
31
Such years were characterized by an earlier period of drought followed by heavier
rainfall than usual. The higher-than-normal temperatures customary of the drought
period lead to significant increases in the vector population and favor the transmission
of AHS.
Although not yet conclusively proved, climate phenomena can and will have an influence
on the global distribution and incidence of various vector-borne diseases of equids
and other species.
Availability of New Vectors
The inadvertent introduction of a particular arthropod vector (e.g., species of mosquito,
midge, or tick) into a country or geographic region for the first time can have significant
consequences if the arthropod becomes successfully established in its new environment
and is shown to be competent to transmit specific vector-borne diseases present in
the country or region. In the past 20 to 30 years, the United States has been the
recipient of two mosquito species, Aedes albopictus (Stegomyia albopicta) or Asian
tiger mosquito and Ochlerotatus japonicus, neither of which was previously known to
occur in the country.32, 33 Both mosquito species have been found to be competent
vectors of certain equine viral encephalomyelitides, especially Eastern equine encephalomyelitis
(EEE) and West Nile encephalitis.
7
Since their known introduction, the two mosquito species have established themselves
and are currently becoming widely distributed in an increasing number of states.
The United States is not unique in respect to the availability of new vectors. Other
countries in both the Northern and the Southern Hemisphere have had similar experiences.
3
Such incursions, mostly of species of mosquito, have been short-lived in some cases,
whereas in other cases the new vector has become permanently established in its new
habitat as exemplified by Aedes albopictus in northeastern Italy.
Migration of Amplifying/Reservoir Hosts or Vectors of Specific Pathogens
Migration of amplifying/reservoir hosts or vectors of specific pathogens can influence
the geographic distribution and occurrence of particular diseases of humans, equids,
and other livestock species and wildlife. Evidence indicates that migrating birds
can be responsible for infrequent cases or reintroduction of certain diseases into
countries in which they did not previously occur.34, 35, 36 This has been starkly
illustrated by the recent rapid global spread of the highly pathogenic avian influenza
virus (H5N1). Birds are also thought to be responsible for the occasional reintroduction
of WNV into various countries in southern Europe and the Middle East from the African
continent.
37
There is little doubt that migratory birds have been primarily responsible for the
spread of this virus from the United States into Mexico, Central America, and certain
Caribbean countries over the past several years. Birds have also been implicated in
the transfer of EEE and Western equine encephalomyelitis (WEE) viruses between southern
and northern hemispheres of the Americas, and vice versa.
The distribution and occurrence of other equine arthropod-borne diseases can be influenced
by the migration of the relevant vectors.
3
African horse sickness, equine encephalosis, and vesicular stomatitis are diseases
that can be spread over considerable distances through wind-borne carriage of infected
Culicoides spp. Wind-borne carriage of infected mosquitoes may similarly account for
the periodic incursions of Japanese encephalitis virus into the Cape York Peninsula
of northeastern Queensland, Australia, from Papua, New Guinea (P.M. Ellis, personal
communication, 2000).
Reliability of Preexport Testing
Without detracting from the value of preexport testing that involves laboratory tests
required by the importing country, as well as live animal inspection, it must be acknowledged
that the certifications of health and freedom from contact with various infectious
diseases accompanying horses being shipped are not always reliable. Of continuing
concern is the need for a greater harmonization between the laboratory testing conducted
prior to export and that carried out in the importing country. There have been repeated
instances where CEM carrier stallions and mares and equine arteritis virus carrier
stallions and infective semen were only detected on postentry laboratory examination.
The importance of a thorough clinical examination performed on all horses prior to
shipment cannot be overemphasized. Horses should not arrive after a transatlantic
flight with overt signs of strangles or other respiratory diseases. The consequences
of such disease introductions can be significant as was amply demonstrated by the
series of outbreaks of equine herpesvirus myeloencephalopathy that occurred in 2006
and which were traced back to a shipment of infected horses from Germany.
Disease Spread from Feral Equids
In countries with feral equid populations, there is the potential risk of spread of
certain diseases to domestic horses. This was well exemplified by the reintroduction
of AHS into the Iberian peninsula in 1987, where the source of virus was a group of
zebra imported into Portugal from Namibia en route to Spain.
Agroterrorism
Before the terrorist attacks on the United States in September 2001 and the subsequent
anthrax letter incidents, little consideration was given to the need to prevent and
respond to a bioterrorist attack against the U.S. agricultural industry and equine
population in particular.
38
Regretfully, past events serve to underscore the reality of the threat posed to agricultural
industries. Whereas the transfer of diseases between countries occurs most often accidentally
or inadvertently, such incursions could also be deliberate, the consequence of an
act of bioterrorism.
In view of the major economic importance of the U.S. equine industry, certain transboundary
diseases could have a huge financial impact if deliberately introduced into the unprotected
equine population. Of the entire array of equine infectious diseases, AHS and VEE
have the potential to cause the most serious and devastating epidemics of disease
among all categories of horses. Neither causal agent would require to be “weaponized”
to achieve such an outcome. Were they to occur, such disease events would also cripple
the ability of the United States to export equids or semen throughout the world.
Clearly, the potential threat of agroterrorism should neither be underappreciated
nor oversensationalized. Widespread acceptance of the reality of the threat is the
important issue, as well as the awareness that a national emerging response plan has
been developed to deal with any bioterrorist-related health emergency involving the
horse or other livestock industries.
Reducing the Risk of International Spread of Equine Diseases
Historically, veterinary regulatory authorities worldwide have responded to the threat
of infectious disease spread inherent in international trade by formulating import
policies that maximize disease prevention safeguards but minimize facilitation of
trade. It has become increasingly difficult, however, for countries to uphold policies
based on overly restrictive import controls in today's global economic climate. They
are perceived in conflict with the overall goal of the WTO, which is to eliminate
or reduce unjustified protectionist barriers to trade among member countries.
9
It is freely accepted that the economic viability and success of the horse industry
worldwide is critically dependent on the ability to ship horses within a state, a
country, or internationally, without excessive restrictions on movement. With the
aim of reducing the level of risk of disease spread from such movements, regulatory
authorities have developed specific control measures to prevent the introduction and
potential dissemination of a range of equine diseases into the importing country.
To assist in formulation of their animal health import policies, the Office International
des Epizootics (OIE), now the World Organization for Animal Health as recognized by
the WTO, has developed a Terrestrial Animal Health Code that provides countries worldwide
with principal control standards for preventing the spread of specific diseases listed
by the OIE, including those of equids.
39
Regardless of country of origin or destination, horses are shipped internationally
under license/permit issued by the appropriate regulatory agent in the exporting country.
This documentation serves as a means of individual animal identification, certification
of health and freedom from contact with various equine diseases, and a declaration
that the exporting country or its region/zone has been confirmed free of evidence
of certain diseases within a particular time frame.
Preexport Requirements
In addition to certification of freedom of the exporting country or region/zone from
specified equine diseases (e.g., AHS, VEE, glanders), current regulations governing
the import of equids into the United States and most other countries require similar
certification with respect to the premises of origin of the horse(s) being exported,
other premises within a stated radius of that location, and most importantly, the
individual animal(s) being exported. Horses must be held in preexport quarantine for
a specified period, during which they are subjected to the necessary clinical examination
and laboratory tests prescribed by the importing country. Of critical importance to
ensuring the integrity of sampling and testing of horses for export is the need for
some form of permanent individual identification such as a unique animal identification
number (microchip) or alternative system of permanent identification (iris scanning,
retinal scanning). Poor or inferior systems of animal identification increase the
potential for willful substitution of horses before shipment and enhance the disease
risks involved.
Postimport Requirements
Assuming all the preexport certification and testing meet the requirements of the
importing country, the horse(s) being shipped are approved for temporary or permanent
entry into that country. Where the United States is the country of destination, the
U.S. Department of Agriculture (USDA) requires that all horses imported from non–AHS-affected
countries are, transported immediately after arrival in a federally sealed conveyance
to a USDA-approved quarantine station closest to the port of entry. The animals are
held in isolation for up to 42 hours, during which they are clinically monitored and
serologically tested for evidence of dourine, glanders, EIA, and EP. Subject to a
satisfactory health report and negative serologic findings for these diseases, horses
are released from quarantine and shipped to their state(s) of destination.
Intact male or female horses over 731 days of age originating in a CEM-affected country
and approved for permanent entry into the United States are required to undergo additional
testing to confirm their freedom from T. equigenitalis, the causal agent of CEM. To
accomplish this, such individuals are shipped in a sealed conveyance to a state that
is federally approved to accept and quarantine stallions and mares from CEM-affected
countries. They are quarantined on a premises approved for that purpose in accordance
with federal and state guidelines and subjected to the necessary testing for CEM.
They are released from quarantine once they have been confirmed not to be carriers
of T. equigenitalis.
Some in the international community advocate that the importing country accept the
reliability of laboratory testing conducted in the exporting country, thereby obviating
the need for a period of postentry quarantine and repeat laboratory testing in the
country of destination. However, experience has shown that failure to provide adequate
post-entry screening of equids for specific infections can pose an unacceptable disease
risk for the horse industry in the importing country such as the United States. For
example, over the past 15 years alone, a total of 36 stallions and mares imported
into the United States from Europe were confirmed carriers of T. equigenitalis on
postentry quarantine and testing. All the animals involved were tested in the countries
of origin and certified free of evidence of this bacterium. If this transboundary
disease had been reintroduced into the United States breeding population through any
of these importations, it could have had major economic repercussions for the horse
breeding industry. Another example of the existing federal postimport inspection and
testing program successfully preventing the introduction of a transboundary disease
is screwworm myiasis. In repeated but infrequent cases, horses imported from certain
South American countries and certified free from this parasite were confirmed infested
with the larvae of Cochliomyia hominivorax in postentry quarantine.
In addition, horses shipped from various European countries have occasionally been
found to be clinically affected with diseases, such as strangles or EHV-1 and EHV-4–related
diseases, on arrival in the United States. Collectively, these incidents bring into
question the reliability of preimport laboratory testing and clinical veterinary inspection
conducted by the exporting country. Also, they reaffirm the importance of maintaining
the current system of postentry safeguards that has served the horse industry well
over the years and has helped to minimize the risk of introduction of various transboundary
diseases.
Clearly, a balance must be struck between allowing movement of equids and providing
the necessary safeguards to prevent the spread of various equine diseases. In light
of the risks associated with international trade in horses and semen, countries need
to have in place adequate postentry risk management strategies. Countries can no longer
be passive to the health risks involved.
Monitoring Surveillance and Reporting of Diseases
Surveillance of equine diseases at a national level and prompt reporting to the relevant
authorities and industry organizations are critical to the effectiveness of national
and international equine health control programs. Essential to any disease or early-warning
monitoring program is the availability of adequate diagnostic capability for the disease(s)
under surveillance. Accuracy and timeliness of a laboratory diagnosis of the suspected
disease are of paramount importance.
In any national reporting system, primary consideration should be given to the equine
diseases listed by the OIE, together with a number of those listed as multispecies
diseases. In addition to OIE notification of occurrences of listed diseases and any
newly emergent disease problem, an informal disease-reporting system is supported
by a growing number of countries worldwide. It requires that each participating country
provide interim and quarterly reports of any confirmed occurrences of a range of equine
diseases, many but not all listed by the OIE, to the International Collating Center
at the Animal Health Trust in the United Kingdom.
The value of timely exchange of accurate, up-to-date information on occurrences of
specific equine diseases at an international level cannot be overemphasized. Such
sharing of information facilitates the process of risk assessment analysis between
countries and enhances opportunities for reduction or elimination of unjustified restrictions
on international trade in equids, semen, and embryos. At a national level, monitoring,
surveillance, and reporting serves as a means of early detection of a disease that
has already gained entry, whether a transboundary or endemic disease. It cannot be
overemphasized how important a role the practicing veterinarian and the horse owner
play in ensuring the success of any surveillance and reporting system and in helping
to monitor the health integrity of their equine industry.
Industry Initiatives
No program for the national or international control of equine infectious diseases
can expect to be successful if it lacks the participation and support of the horse
industry. With this in mind, several international groups have been formed over the
years that represent the racing, equestrian sports, and breeding sectors of the industry.
They include the Federation of Horseracing Authorities Permanent Liaison Committee
on the International Movement of Horses, the FEI, and an International Thoroughbred
Breeders' Federation. These respective organizations or groups are broadly representative
of the international community of countries with significant horse-breeding/performance
industries. Their overall goal is to enlist industry involvement in identifying specific
equine health or related issues that adversely affect international movement of horses
and to seek ways to resolve them.
Within the realm of industry initiatives, the FEI has recently sought the support
of the OIE in seeking to obtain a more equitable balance between facilitation of international
movement of high-value performance horses and meeting the testing requirements of
importing countries. It has been recognized for many years that the risk of disease
transfer is not necessarily equivalent among different categories of horses. For several
reasons, high-value performance horses can be considered a lower risk category. Because
of the frequency with which they travel internationally, they are tested more often
and monitored more closely for a range of the most important diseases. Additionally,
their vaccination status for diseases of significance is likely to be current. The
goal of this initiative is to establish a strategic framework for countries and regions
to harmonize their approach to sanitary conditions for the international movement
of performance horses. Objectives are to (1) maintain the high health status of performance
horses and minimize the risk of transboundary disease transmission while removing
unjustified health requirements; (2) ensure the welfare of the horses during transportation;
and (3) educate government regulatory authorities, industry, and stakeholders on OIE
standards and biosecurity requirements relating to the international movement of performance
horses.
Yet, another example of an industry initiative is the concept of establishing an “equine
disease-free zone” in countries wishing to host an internationally recognized performance
event but are unable to do so because of the disease status of their resident equine
population. The aims of developing such a facility are twofold: (1) to enable equine
athletes from other countries to compete in an international event without the risk
of being exposed to a disease or diseases endemic in the host country and (2) to protect
the host country's equine population from a disease introduced by a competing country's
horses. Proof of concept that this was achievable was the “Equine Disease-Free Facility”
that was developed in Guangdong Province in PR China. It enabled the country to host
the equine program of the 2010 Asian Games. The detailed advance planning, discussions,
and negotiations that took place between the relevant international agencies and ruling
bodies and the national and provincial animal health authorities in China were crucial
to ensuring the success of this unique initiative. Under similar circumstances in
the future, other countries may adopt the same approach if intent on hosting international
performance events.
Greater control over the international spread of equine diseases is an achievable
goal. However, attaining it is only possible if horse industries and animal health
regulatory authorities worldwide work cooperatively together toward that end.